T-Cell Responses to SARS-CoV-2 in COVID-Recovered MS Patients Treated With Ocrelizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
T-Cell Responses to SARS-CoV-2 in Multiple Sclerosis Patients Treated With Ocrelizumab Healed From COVID-19 With Absent or Low Anti-Spike Antibody Titers
Mult Scler Relat Disord 2021 Jul 21;[EPub Ahead of Print], M Iannetta, D Landi, G Cola, V Malagnino, E Teti, D Fraboni, F Buccisano, S Grelli, L Coppola, L Campogiani, M Andreoni, GA Marfia, L SarmatiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.